comprehensive -WSS

comprehensive

author：entertainment 2025-10-01 23:00:52 - browse：2491

Outgoing Bristol CEO Giovanni Caforio Emilie Pickering for STAT

It’s changing of the guard time at pharmaceutical giant Bristol Myers Squibb. On Wednesday, CEO Giovanni Caforio will step down. He’ll be replaced by Christopher Boerner, who is currently chief operating officer.

When Caforio took over in May 2015, Bristol was known as a big pharmaceutical firm with the high-flying stock of a biotechnology company, largely due to its role as the company that brought cancer immunotherapy to market. But Bristol stumbled in 2016 when its immunotherapy Opdivo failed to help patients with non-small cell cancer more than chemotherapy. Opdivo remained a big seller, but its failure allowed Merck’s rival Keytruda to move into position to become the best-selling medicine in the world. In 2019, Caforio tried to flip the script, buying the biotech Celgene for $74 billion.

STAT recently sat down with Caforio, 59, to look back on what went wrong and right with his tenure. He also reflected on what it meant to be a physician — and the son of a physician. “We were speaking about patient stories over lunch and dinner, when I was a kid, and I think that drove my passion for medicine,” he said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Indictment alleges Trump's ex

Wikipedia

knowledge

WSS

Mark Cuban is blaming the wrong people for high drug costs

Maui wildfire now ranks as the fifth

How I ended up pumping milk in a bathroom stall at JPM 2024

Biotech reporter’s notebook: A sunnier mood at JPM 2024

Senators push IRS to launch nonprofit hospital probe

Treatments for cramps don't cut it. Why aren't there better options?

focus

comprehensive

explore

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Health AI: on the border between health care and tech

Virginia high school admissions case could be legal follow

Designating disabled people as health disparity population is crucial

George Santos makes 1st court appearance after pleading not guilty to 13 counts

GSK to buy asthma

Activists slam private health insurers over coverage restrictions

Risky weight loss products often used by teens globally, per study

Duchenne breakthrough therapy leaves behind pioneering families

Doulas covered by Medicaid under New York's new plan

focus

Hospitals are dialing back on venture capital investing

Timeline: How the deadly wildfires took over Maui day by day

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

New England Journal of Medicine addresses racist history, slavery

New Medicare drug pricing powers could soon be upended in court

JPM 2024: Nvidia claims we're in biological revolution. Are we?

Wikipedia

explore

knowledge

entertainment